Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Meera Mahalingam, Ph.D., M.B.,B.S.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Bae E, Leone D, Konnikov N, Mahalingam M. Demographics, Risk Factors, and Incidence of Melanoma in Patients in the New England VA Healthcare system. Mil Med. 2019 May 01; 184(5-6):e408-e416. PMID: 30395278.
    Citations:    Fields:    
  2. Turkowski Y, Konnikov N, Mahalingam M. Necrotizing Granulomas in a Patient With Psoriasis and Sarcoidosis After Adalimumab-Medication-Induced Reaction or Reactivation of Latent Disease? Am J Dermatopathol. 2019 Feb 28. PMID: 30839343.
    Citations:    
  3. Yang S, Leone DA, Biswas A, Deng A, Jukic D, Singh R, Sundram U, Mahalingam M. Concordance of somatic mutation profiles (BRAF,NRAS, and TERT) and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples. Hum Pathol. 2018 Dec; 82:206-214. PMID: 30120967.
    Citations:    Fields:    
  4. Mahalingam M. Laser Capture Microdissection: Insights into Methods and Applications. Methods Mol Biol. 2018; 1723:1-17. PMID: 29344852.
    Citations:    Fields:    Translation:Humans
  5. Bae E, White P, Brophy M, Lichtman M, Krathen MS, Mahalingam M. Cutaneous Rosai-Dorfman Disease With Linear Lesions and Monoclonal Gammopathy. Am J Dermatopathol. 2017 Oct; 39(10):776-781. PMID: 28930107.
    Citations:    Fields:    Translation:Humans
  6. Frydenlund N, Mahalingam M. PD-L1 and immune escape: insights from melanoma and other lineage-unrelated malignancies. Hum Pathol. 2017 08; 66:13-33. PMID: 28694003.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  7. Chung HJ, Kafle SU, Lam C, Mahalingam M. Annular Plaque on the Inner Thigh. Am J Dermatopathol. 2017 Jul; 39(7):551-552. PMID: 28632570.
    Citations:    Fields:    
  8. Chung HJ, Kafle SU, Lam C, Mahalingam M. An Annular Plaque on the Inner Thigh. Am J Dermatopathol. 2017 Jul; 39(7):e85. PMID: 28632574.
    Citations:    Fields:    
  9. Mahalingam M. MSH6, Past and Present and Muir-Torre Syndrome-Connecting the Dots. Am J Dermatopathol. 2017 Apr; 39(4):239-249. PMID: 28323777.
    Citations: 1     Fields:    Translation:Humans
  10. Mahalingam M. Lack of specificity of cytokeratin-15 loss in scarring alopecias. J Am Acad Dermatol. 2017 04; 76(4):e135-e136. PMID: 28325418.
    Citations:    Fields:    Translation:Humans
  11. Frydenlund N, Leone D, Yang S, Hoang MP, Deng A, Hernandez-Perez M, Singh R, Biswas A, Yaar R, Mahalingam M. Tumoral PD-L1 expression in desmoplastic melanoma is associated with depth of invasion, tumor-infiltrating CD8 cytotoxic lymphocytes and the mixed cytomorphological variant. Mod Pathol. 2017 03; 30(3):357-369. PMID: 28084337.
    Citations: 6     Fields:    Translation:HumansCells
  12. Mahalingam M. NF1 and Neurofibromin: Emerging Players in the Genetic Landscape of Desmoplastic Melanoma. Adv Anat Pathol. 2017 Jan; 24(1):1-14. PMID: 27941538.
    Citations: 4     Fields:    Translation:Humans
  13. Mitchell B, Leone D, Yang S, Khan A, Mahalingam M, Dhingra J. BRAF and epithelial-mesenchymal transition in papillary thyroid carcinoma - challenging the roles of Snail and E-Cadherin? Am J Transl Res. 2016; 8(11):5076-5086. PMID: 27904709.
    Citations:    
  14. Lawrence NF, Hammond MR, Frederick DT, Su Y, Dias-Santagata D, Deng A, Selim MA, Mahalingam M, Flaherty KT, Hoang MP. Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome. J Am Acad Dermatol. 2016 Sep; 75(3):595-602. PMID: 27543214.
    Citations: 1     Fields:    Translation:Humans
  15. Yang S, Leone D, Frydenlund N, Hoang M, Deng A, Hernandez-Perez M, Biswas A, Singh R, Yaar R, Mahalingam M. Frequency of telomerase reverse transcripter promoter mutations in desmoplastic melanoma subtypes: analyses of 76 cases. Melanoma Res. 2016 08; 26(4):361-6. PMID: 27244099.
    Citations: 2     Fields:    Translation:Humans
  16. Mitchell B, Dhingra JK, Mahalingam M. BRAF and Epithelial-Mesenchymal Transition: Lessons From Papillary Thyroid Carcinoma and Primary Cutaneous Melanoma. Adv Anat Pathol. 2016 Jul; 23(4):244-71. PMID: 27145091.
    Citations: 2     Fields:    Translation:Humans
  17. Kadokura A, Frydenlund N, Leone DA, Yang S, Hoang MP, Deng A, Hernandez-Perez M, Biswas A, Singh R, Yaar R, Mahalingam M. Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver? Hum Pathol. 2016 07; 53:82-90. PMID: 26980030.
    Citations: 1     Fields:    Translation:Humans
  18. Mitchell B, Leone DA, Feller JK, Yang S, Mahalingam M. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin? Hum Pathol. 2016 06; 52:19-27. PMID: 26980024.
    Citations: 1     Fields:    Translation:HumansCells
  19. Succaria F, Collier M, Mahalingam M. Zoledronic Acid-Induced Interface Dermatitis. Am J Dermatopathol. 2015 Dec; 37(12):933-5. PMID: 26588338.
    Citations:    Fields:    Translation:Humans
  20. Filitis DC, Rauh J, Mahalingam M. The HGF-cMET signaling pathway in conferring stromal-induced BRAF-inhibitor resistance in melanoma. Melanoma Res. 2015 Dec; 25(6):470-8. PMID: 26317169.
    Citations: 4     Fields:    Translation:HumansCells
  21. Mahalingam M, Reddy VB. Mycosis Fungoides, Then and Now… Have We Travelled? Adv Anat Pathol. 2015 Nov; 22(6):376-83. PMID: 26452212.
    Citations:    Fields:    Translation:Humans
  22. Succaria F, Rosenbaum M, Goldberg LJ, Mahalingam M. Dark Brown Plaques and Patches on the Breast and Areola in a 14-Year-Old Female. Nevoid hyperkeratosis of the areola and breast. Am J Dermatopathol. 2015 Aug; 37(8):621-2, 659. PMID: 26193708.
    Citations: 1     Fields:    Translation:Humans
  23. Frydenlund N, Mahalingam M. Desmoplastic melanoma, neurotropism, and neurotrophin receptors--what we know and what we do not. Adv Anat Pathol. 2015 Jul; 22(4):227-41. PMID: 26050260.
    Citations:    Fields:    Translation:Humans
  24. Frydenlund N, Leone DA, Mitchell B, Abbas O, Dhingra J, Mahalingam M. Perineural invasion in cutaneous squamous cell carcinoma: role of immunohistochemistry, anatomical site, and the high-affinity nerve growth factor receptor TrkA. Hum Pathol. 2015 Aug; 46(8):1209-16. PMID: 26072357.
    Citations: 2     Fields:    Translation:Humans
  25. Frydenlund N, Leone DA, Mitchell B, Yang S, Deng A, Hoang MP, Mahalingam M. Neurotrophin receptors and perineural invasion in desmoplastic melanoma. J Am Acad Dermatol. 2015 May; 72(5):851-8. PMID: 25752716.
    Citations:    Fields:    Translation:Humans
  26. Marszalek RM, Bae-Harboe YS, Mahalingam M, Masterpol K. Painless penile papule. J Fam Pract. 2015 Mar; 64(3):185-8. PMID: 25789346.
    Citations:    Fields:    Translation:Humans
  27. Aung PP, Goldberg LJ, Mahalingam M, Bhawan J. Cutaneous Myopericytoma: A Report of 3 Cases and Review of the Literature. Dermatopathology (Basel). 2015 Jan-Mar; 2(1):9-14. PMID: 27047931.
    Citations: 2     
  28. Aung PP, Mahalingam M. Pseudoxanthoma elasticum-like change adjacent to a benign adnexal neoplasm: a histopathologic reaction pattern. Am J Dermatopathol. 2015 Feb; 37(2):157-9. PMID: 25365498.
    Citations:    Fields:    Translation:Humans
  29. Varada S, Mahalingam M. Mutation stability in primary and metastatic melanoma: what we know and what we don't. Histol Histopathol. 2015 Jul; 30(7):763-70. PMID: 25585249.
    Citations: 2     Fields:    Translation:HumansCells
  30. Mitchell B, Leone D, Feller JK, Bondzie P, Yang S, Park HY, Mahalingam M. Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with established histopathologic prognosticators and the BRAF status. Melanoma Res. 2014 Dec; 24(6):621-5. PMID: 25211166.
    Citations: 1     Fields:    Translation:Humans
  31. Chowdary S, Mahalingam M, Vashi NA. Reading between the layers: early histopathological findings in exogenous ochronosis. Am J Dermatopathol. 2014 Dec; 36(12):989-91. PMID: 25415140.
    Citations: 2     Fields:    Translation:HumansCells
  32. Aung PP, Leone D, Feller JK, Yang S, Hernandez M, Yaar R, Singh R, Helm T, Mahalingam M. Microvessel density, lymphovascular density, and lymphovascular invasion in primary cutaneous melanoma-correlation with histopathologic prognosticators and BRAF status. Hum Pathol. 2015 Feb; 46(2):304-12. PMID: 25537974.
    Citations: 3     Fields:    Translation:Humans
  33. Perez-Chua T, Miller DD, Mahalingam M. Erythema nodosum of non-lower-extremity sites: a histopathologic reappraisal. G Ital Dermatol Venereol. 2016 Dec; 151(6):710-713. PMID: 25407105.
    Citations:    Fields:    Translation:Humans
  34. Dadzie OE, Jablonski NG, Mahalingam M, Dupuy A, Petit A. Skin cancer, photoprotection, and skin of color. J Am Acad Dermatol. 2014 Sep; 71(3):586. PMID: 25128105.
    Citations: 1     Fields:    Translation:Humans
  35. Marghalani S, Feller JK, Mahalingam M, Mirzabeigi M. Huntingtin interacting protein 1 as a histopathologic adjunct in the diagnosis of Merkel cell carcinoma. Int J Dermatol. 2015 Jun; 54(6):640-7. PMID: 25070010.
    Citations: 2     Fields:    Translation:Humans
  36. Mitchell B, Leone D, Feller K, Menon S, Bondzie P, Yang S, Park HY, Mahalingam M. Protein expression of the chemokine receptor CXCR4 and its ligand CXCL12 in primary cutaneous melanoma--biomarkers of potential utility? Hum Pathol. 2014 Oct; 45(10):2094-100. PMID: 25130395.
    Citations: 1     Fields:    Translation:Humans
  37. Aung PP, Bowker B, Masterpol KS, Mahalingam M. Disseminated noninterstitial granulomatous dermatitis as a cutaneous manifestation of the preleukemic state in a patient with myelodysplasia and ulcerative colitis--apropos a case and review of the literature. Am J Dermatopathol. 2014 Jul; 36(7):e117-20. PMID: 24950421.
    Citations: 2     Fields:    Translation:Humans
  38. Forloni M, Dogra SK, Dong Y, Conte D, Ou J, Zhu LJ, Deng A, Mahalingam M, Green MR, Wajapeyee N. miR-146a promotes the initiation and progression of melanoma by activating Notch signaling. Elife. 2014 Feb 18; 3:e01460. PMID: 24550252.
    Citations: 27     Fields:    Translation:HumansAnimalsCells
  39. Chung HJ, Mahalingam M. Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma - implications for therapeutic strategies and targeted therapies. Expert Rev Anticancer Ther. 2014 May; 14(5):621-39. PMID: 24506089.
    Citations: 7     Fields:    Translation:Humans
  40. Gan SD, Mahalingam M, Miller DD. Fever and a solitary papule on the foot. JAMA Dermatol. 2014 Feb; 150(2):203-4. PMID: 24369375.
    Citations:    Fields:    Translation:HumansCells
  41. Lee JJ, Mochel MC, Piris A, Boussahmain C, Mahalingam M, Hoang MP. p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases. Hum Pathol. 2014 May; 45(5):1078-83. PMID: 24746214.
    Citations: 4     Fields:    Translation:Humans
  42. Aung PP, Batrani M, Yang S, Mahalingam M. Apoptosis and in situ and invasive squamous cell carcinoma in sun-exposed sites. Am J Dermatopathol. 2013 Dec; 35(8):797-803. PMID: 23455334.
    Citations:    Fields:    Translation:Humans
  43. Aung PP, Ballester LY, Abdullaev Z, Pack SD, Cummins DL, Mahalingam M. ER/PR positive epidermotropic primary cutaneous eccrine carcinoma as a cutaneous manifestation of MEN 2B. J Am Acad Dermatol. 2013 Dec; 69(6):e310-2. PMID: 24238193.
    Citations:    Fields:    Translation:Humans
  44. Filitis DC, Mahalingam M. Cutaneous adverse events to type I BRAF inhibitors: an analysis of effects associated with each inhibitor and therapeutic time interval to onset. Am J Clin Dermatol. 2013 Dec; 14(6):461-71. PMID: 24048637.
    Citations:    Fields:    Translation:Humans
  45. Aung PP, Ballester LY, Mahalingam M. Histopathology of Keratoacanthoma Revisited: Utility of Orificial Size as a Diagnostic Adjunct. Int J Surg Pathol. 2014 Jun; 22(4):316-25. PMID: 24284133.
    Citations:    Fields:    Translation:Humans
  46. Fang M, Xia F, Mahalingam M, Virbasius CM, Wajapeyee N, Green MR. MEN1 is a melanoma tumor suppressor that preserves genomic integrity by stimulating transcription of genes that promote homologous recombination-directed DNA repair. Mol Cell Biol. 2013 Jul; 33(13):2635-47. PMID: 23648481.
    Citations: 11     Fields:    Translation:HumansCells
  47. Feller JK, Mahalingam M. c-myc and cutaneous vascular neoplasms. Am J Dermatopathol. 2013 May; 35(3):364-9. PMID: 23221487.
    Citations: 4     Fields:    Translation:HumansCells
  48. Biswas A, Richards JE, Massaro J, Mahalingam M. Mast cells in cutaneous tumors: innocent bystander or maestro conductor? Int J Dermatol. 2014 Jul; 53(7):806-11. PMID: 23621615.
    Citations: 2     Fields:    Translation:HumansCells
  49. Abbas O, Mahalingam M. The grenz zone. Am J Dermatopathol. 2013 Feb; 35(1):83-91. PMID: 23348142.
    Citations: 2     Fields:    Translation:Humans
  50. Mahalingam M, Hoang MP. Porocarcinoma: an exceedingly rare tumor or a tumor eclipse phenomenon?--Reply. Hum Pathol. 2013 Mar; 44(3):449. PMID: 23290010.
    Citations:    Fields:    Translation:Humans
  51. Feller JK, Yang S, Mahalingam M. Immunohistochemistry with a mutation-specific monoclonal antibody as a screening tool for the BRAFV600E mutational status in primary cutaneous malignant melanoma. Mod Pathol. 2013 Mar; 26(3):414-20. PMID: 23041829.
    Citations: 12     Fields:    Translation:HumansCells
  52. Hernández-Pérez M, El-hajahmad M, Massaro J, Mahalingam M. Expression of gelatinases (MMP-2, MMP-9) and gelatinase activator (MMP-14) in actinic keratosis and in in situ and invasive squamous cell carcinoma. Am J Dermatopathol. 2012 Oct; 34(7):723-8. PMID: 22534634.
    Citations: 6     Fields:    Translation:HumansCells
  53. Silva CY, Brown KL, Kurban AK, Mahalingam M. Psoriatic alopecia - fact or fiction? A clinicohistopathologic reappraisal. Indian J Dermatol Venereol Leprol. 2012 Sep-Oct; 78(5):611-9. PMID: 22960818.
    Citations: 3     Fields:    Translation:Humans
  54. Hernández-Pérez M, Mahalingam M. Matrix metalloproteinases in health and disease: insights from dermatopathology. Am J Dermatopathol. 2012 Aug; 34(6):565-79. PMID: 22814316.
    Citations: 4     Fields:    Translation:HumansCells
  55. Setia N, Abbas O, Sousa Y, Garb JL, Mahalingam M. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma. Mod Pathol. 2012 Aug; 25(8):1169-75. PMID: 22555176.
    Citations: 9     Fields:    Translation:HumansCells
  56. Biswas A, Mahalingam M. Cutaneous clear cell neoplasms: a histopathological reappraisal. Am J Dermatopathol. 2012 May; 34(3):237-54. PMID: 22513804.
    Citations: 1     Fields:    Translation:HumansCells
  57. Miller DD, Yaar R, Posnik O, Karolow W, Mahalingam M. Reactive granular histiocytosis secondary to arthroplasty prosthesis: a novel reaction pattern. J Cutan Pathol. 2012 May; 39(5):558-61. PMID: 22515227.
    Citations:    Fields:    Translation:Humans
  58. Jacob RS, Silva CY, Powers JG, Schieke SM, Mendese G, Burlingame RW, Miller DD, Wolpowitz D, Graber E, Mahalingam M. Levamisole-induced vasculopathy: a report of 2 cases and a novel histopathologic finding. Am J Dermatopathol. 2012 Apr; 34(2):208-13. PMID: 22094232.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  59. Schieke SM, Sharaf MA, Lerner A, Rünger TM, Mahalingam M. Primary cutaneous CD56 positive lymphoma: a diagnostic conundrum in an unusual case of lymphoma. J Cutan Pathol. 2012 May; 39(5):540-4. PMID: 22519525.
    Citations: 1     Fields:    Translation:HumansCells
  60. Park E, Yang S, Emley A, DeCarlo K, Richards J, Mahalingam M. Lack of correlation between immunohistochemical expression of CKIT and KIT mutations in atypical acral nevi. Am J Dermatopathol. 2012 Feb; 34(1):41-6. PMID: 22094233.
    Citations: 3     Fields:    Translation:Humans
  61. Silva CY, Mahalingam M. Adenomatous eccrine metaplasia--a novel reaction pattern. Am J Dermatopathol. 2012 Feb; 34(1):47-53. PMID: 22197858.
    Citations:    Fields:    Translation:Humans
  62. Mahalingam M, Richards JE, Selim MA, Muzikansky A, Hoang MP. An immunohistochemical comparison of cytokeratin 7, cytokeratin 15, cytokeratin 19, CAM 5.2, carcinoembryonic antigen, and nestin in differentiating porocarcinoma from squamous cell carcinoma. Hum Pathol. 2012 Aug; 43(8):1265-72. PMID: 22285043.
    Citations: 2     Fields:    Translation:Humans
  63. Miller DD, Emley A, Yang S, Richards JE, Lee JE, Deng A, Hoang MP, Mahalingam M. Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal. Mod Pathol. 2012 Apr; 25(4):505-15. PMID: 22157936.
    Citations: 11     Fields:    Translation:Humans
  64. Gloeckner Powers J, Miller DD, Mahalingam M, Phillips TJ. ??????Slowly growing, ulcerating nodule on the posterior ankle ?. Wounds. 2011 Oct; 23(10):320-1. PMID: 25881109.
    Citations:    Fields:    
  65. Rushing EC, Stine MJ, Hahn SJ, Shea S, Eller MS, Naif A, Khanna S, Westra WH, Jungbluth AA, Busam KJ, Mahalingam M, Alani RM. Neuropilin-2: a novel biomarker for malignant melanoma? Hum Pathol. 2012 Mar; 43(3):381-9. PMID: 21840568.
    Citations: 7     Fields:    Translation:HumansCells
  66. Silva CY, Goldberg LJ, Mahalingam M, Bhawan J, Wolpowitz D. Nests with numerous SOX10 and MiTF-positive cells in lichenoid inflammation: pseudomelanocytic nests or authentic melanocytic proliferation? J Cutan Pathol. 2011 Oct; 38(10):797-800. PMID: 21812802.
    Citations: 3     Fields:    Translation:HumansCells
  67. Hoang M, Mahalingam M. Methodology matters, but…. J Cutan Pathol. 2012 Jan; 39(1):78-9; author reply 83-7. PMID: 21752058.
    Citations:    Fields:    Translation:HumansCells
  68. Mahalingam M. Renal transplant, immunosuppression and skin cancer: "the good, the bad and the ugly". Eur J Dermatol. 2011 Mar-Apr; 21(2):156. PMID: 21454150.
    Citations:    Fields:    Translation:Humans
  69. Dadzie OE, Neat M, Emley A, Bhawan J, Mahalingam M. Molecular diagnostics-an emerging frontier in dermatopathology. Am J Dermatopathol. 2011 Feb; 33(1):1-13; quiz 14-6. PMID: 20664321.
    Citations: 1     Fields:    Translation:Humans
  70. Decarlo K, Emley A, Dadzie OE, Mahalingam M. Laser capture microdissection: methods and applications. Methods Mol Biol. 2011; 755:1-15. PMID: 21761290.
    Citations: 16     Fields:    Translation:Humans
  71. Mahalingam M, Srivastava A, Hoang MP. Expression of stem-cell markers (cytokeratin 15 and nestin) in primary adnexal neoplasms-clues to etiopathogenesis. Am J Dermatopathol. 2010 Dec; 32(8):774-9. PMID: 20700038.
    Citations: 1     Fields:    Translation:HumansCells
  72. Emley A, Nguyen LP, Yang S, Mahalingam M. Somatic mutations in GNAQ in amelanotic/hypomelanotic blue nevi. Hum Pathol. 2011 Jan; 42(1):136-40. PMID: 21056896.
    Citations: 6     Fields:    Translation:Humans
  73. Abbas O, Richards JE, Yaar R, Mahalingam M. Stem cell markers (cytokeratin 15, cytokeratin 19 and p63) in in situ and invasive cutaneous epithelial lesions. Mod Pathol. 2011 Jan; 24(1):90-7. PMID: 20852595.
    Citations: 7     Fields:    Translation:HumansCells
  74. Abbas O, Mahalingam M. Desmoplasia: not always a bad thing. Histopathology. 2011 Apr; 58(5):643-59. PMID: 20718872.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  75. Abbas O, Richards JE, Mahalingam M. Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma. Mod Pathol. 2010 Nov; 23(11):1535-43. PMID: 20711172.
    Citations: 6     Fields:    Translation:HumansCells
  76. Pongpudpunth M, Bhawan J, Al-Natour SH, Mahalingam M. Nestin-positive stem cells in neurofibromas from patients with neurofibromatosis type 1-tumorigenic or incidental? Am J Dermatopathol. 2010 Aug; 32(6):574-7. PMID: 20520523.
    Citations: 1     Fields:    Translation:HumansCells
  77. Abbas O, Reddy K, Demierre MF, Blanchard RA, Mahalingam M. Epidermotropic metastatic mucoepidermoid carcinoma. Am J Dermatopathol. 2010 Jul; 32(5):505-8. PMID: 20489572.
    Citations:    Fields:    Translation:Humans
  78. Mahalingam M, Hoang MP. D2-40 expression in primary scarring and nonscarring alopecia. Am J Dermatopathol. 2010 Jul; 32(5):427-31. PMID: 20414092.
    Citations:    Fields:    Translation:HumansCells
  79. Ronaghy A, Yaar R, Goldberg LJ, Mahalingam M, Bhawan J. Perineural involvement: what does it mean? Am J Dermatopathol. 2010 Jul; 32(5):469-76. PMID: 20526173.
    Citations:    Fields:    Translation:Humans
  80. Mahoney A, Garg A, Wolpowitz D, Mahalingam M. Atypical granular cell tumor-apropos of a case with indeterminate malignant potential. Am J Dermatopathol. 2010 Jun; 32(4):370-3. PMID: 20514678.
    Citations: 6     Fields:    Translation:Humans
  81. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Role for IGFBP7 in senescence induction by BRAF. Cell. 2010 May 28; 141(5):746-7. PMID: 20510919.
    Citations: 16     Fields:    Translation:HumansCells
  82. Yaar R, Rothman K, Mahalingam M. When dead cells tell tales-cutaneous involvement by precursor T-cell acute lymphoblastic lymphoma with an uncommon phenotype. Am J Dermatopathol. 2010 Apr; 32(2):183-6. PMID: 20010405.
    Citations:    Fields:    Translation:Humans
  83. Decarlo K, Yang S, Emley A, Wajapeyee N, Green M, Mahalingam M. Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7--challenging the concept of dysplastic nevi as precursor lesions? Hum Pathol. 2010 Jun; 41(6):886-94. PMID: 20233623.
    Citations: 7     Fields:    Translation:Humans
  84. Mahalingam M, Nguyen LP, Richards JE, Muzikansky A, Hoang MP. The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin. Mod Pathol. 2010 May; 23(5):713-9. PMID: 20190734.
    Citations: 8     Fields:    Translation:Humans
  85. Hoang MP, Mahalingam M, Selim MA. Immunohistochemistry in the diagnosis of cutaneous neoplasms. Future Oncol. 2010 Jan; 6(1):93-109. PMID: 20021211.
    Citations: 1     Fields:    Translation:Humans
  86. Mahalingam M. On oncogenic BRAF, melanomagenesis and organ transplant recipients--"the more we know, the less we understand". Eur J Dermatol. 2010 Mar-Apr; 20(2):143. PMID: 20007066.
    Citations:    Fields:    Translation:Humans
  87. Alberta-Wszolek L, Mousette AM, Mahalingam M, Levin NA. Linear IgA bullous dermatosis following influenza vaccination. Dermatol Online J. 2009 Nov 15; 15(11):3. PMID: 19951639.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  88. Wajapeyee N, Kapoor V, Mahalingam M, Green MR. Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines. Mol Cancer Ther. 2009 Nov; 8(11):3009-14. PMID: 19861408.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  89. Abbas O, Mahalingam M. Tumor of the follicular infundibulum: an epidermal reaction pattern? Am J Dermatopathol. 2009 Oct; 31(7):626-33. PMID: 19633534.
    Citations: 4     Fields:    Translation:Humans
  90. Emley A, Yang S, Wajapeyee N, Green MR, Mahalingam M. Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations. J Cutan Pathol. 2010 Mar; 37(3):344-9. PMID: 19788444.
    Citations: 4     Fields:    Translation:Humans
  91. Mahalingam M. When a negative is a positive! J Cutan Pathol. 2009 Sep; 36(9):1022-3. PMID: 19674207.
    Citations:    Fields:    Translation:Humans
  92. Pozdnyakova O, Hoang MM, Dresser KA, Mahalingam M. Prognostic value of E-cadherin, beta-catenin, CD44v6, and HER2/neu in metastatic cutaneous adenocarcinoma. Arch Pathol Lab Med. 2009 Aug; 133(8):1285-90. PMID: 19653727.
    Citations: 1     Fields:    Translation:Humans
  93. Yu Y, Demierre MF, Mahalingam M. Anaplastic Kaposi's sarcoma: an uncommon histologic phenotype with an aggressive clinical course. J Cutan Pathol. 2010 Oct; 37(10):1088-91. PMID: 19638066.
    Citations: 1     Fields:    Translation:HumansCells
  94. Pongpudpunth M, Keady M, Mahalingam M. Morphometric analyses of elastic tissue fibers in dermatofibroma: clues to etiopathogenesis? J Cutan Pathol. 2009 Oct; 36(10):1083-8. PMID: 19615002.
    Citations:    Fields:    Translation:Humans
  95. Abbas O, Mahalingam M. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm. J Cutan Pathol. 2009 Jun; 36(6):613-9. PMID: 19515040.
    Citations: 18     Fields:    Translation:Humans
  96. Fong G, Capaldi L, Sweeney SM, Wiss K, Mahalingam M. Congenital Darier disease. J Am Acad Dermatol. 2008 Aug; 59(2 Suppl 1):S50-1. PMID: 18625387.
    Citations:    Fields:    Translation:Humans
  97. Pozdnyakova O, Mahalingam M. Involvement of the bulge region in primary scarring alopecia. J Cutan Pathol. 2008 Oct; 35(10):922-5. PMID: 18537862.
    Citations: 4     Fields:    Translation:HumansCells
  98. Mahalingam M. Quality assurance and continuing medical education in dermatopathology - the ASDP way. J Cutan Pathol. 2008 May; 35(5):516-9. PMID: 18399813.
    Citations:    Fields:    Translation:Humans
  99. Pozdnyakova O, Garg A, Mahalingam M. Nodular vasculitis - a novel cutaneous manifestation of autoimmune colitis. J Cutan Pathol. 2008 Mar; 35(3):315-9. PMID: 18251747.
    Citations: 1     Fields:    Translation:Humans
  100. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008 Feb 08; 132(3):363-74. PMID: 18267069.
    Citations: 302     Fields:    Translation:HumansAnimalsCells
  101. Dadzie OE, Mahalingam M, Parada M, El Helou T, Philips T, Bhawan J. Adverse cutaneous reactions to soft tissue fillers--a review of the histological features. J Cutan Pathol. 2008 Jun; 35(6):536-48. PMID: 18201242.
    Citations: 10     Fields:    Translation:Humans
  102. Pozdnyakova O, Mahalingam M. CD99 - much ado about nothing? J Cutan Pathol. 2008 Jan; 35(1):86-7. PMID: 18096002.
    Citations:    Fields:    Translation:Humans
  103. Bordeaux JS, O'Brien M, Mahalingam M, Wiss K. Clinicopathologic challenge. Disseminated fusariosis. Int J Dermatol. 2008 Jan; 47(1):13-4. PMID: 18173593.
    Citations:    Fields:    Translation:HumansAnimals
  104. Hoang MP, Dresser KA, Kapur P, High WA, Mahalingam M. Microcystic adnexal carcinoma: an immunohistochemical reappraisal. Mod Pathol. 2008 Feb; 21(2):178-85. PMID: 18065959.
    Citations: 7     Fields:    Translation:Humans
  105. Chhibber V, Dresser K, Mahalingam M. MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir-Torre syndrome. Mod Pathol. 2008 Feb; 21(2):159-64. PMID: 18065960.
    Citations: 8     Fields:    Translation:HumansCells
  106. Leboeuf NR, Mahalingam M. Acanthomatous superficial sebaceous hamartoma? A study of six cases with clarification of the nomenclature. J Cutan Pathol. 2007 Nov; 34(11):865-70. PMID: 17944728.
    Citations: 3     Fields:    Translation:Humans
  107. Mendese G, Mahalingam M. Histopathology of Gottron's papules--utility in diagnosing dermatomyositis. J Cutan Pathol. 2007 Oct; 34(10):793-6. PMID: 17880586.
    Citations: 2     Fields:    Translation:Humans
  108. Lisovsky M, Hoang MP, Dresser KA, Kapur P, Bhawan J, Mahalingam M. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans. Mod Pathol. 2008 Jan; 21(1):31-8. PMID: 17885669.
    Citations: 2     Fields:    Translation:Humans
  109. Chhibber V, Lyle S, Mahalingam M. Ductal eccrine carcinoma with squamous differentiation: apropos a case. J Cutan Pathol. 2007 Jun; 34(6):503-7. PMID: 17518781.
    Citations: 3     Fields:    Translation:Humans
  110. Coburn V, Radfar A, Snook D, Mahalingam M. Cutaneous oncocytoma - a report of three cases and review of the literature. J Cutan Pathol. 2007 Apr; 34(4):355-9. PMID: 17381809.
    Citations: 4     Fields:    Translation:Humans
  111. Garg A, Mahalingam M, Alavian C. Pruritic patches on the back and papules on the legs. Primary localized cutaneous amyloidosis (PLCA) (cutaneous lichen amyloidosis and macular amyloidosis). Arch Dermatol. 2007 Feb; 143(2):255-60. PMID: 17310008.
    Citations: 1     Fields:    Translation:Humans
  112. Pattee SF, Bordeaux J, Mahalingam M, Nitzan YB, Maloney ME. Verrucous carcinoma of the scalp. J Am Acad Dermatol. 2007 Mar; 56(3):506-7. PMID: 17141366.
    Citations: 4     Fields:    Translation:HumansCells
  113. Mahalingam M, Bhawan J. Cutaneous anaplastic large cell lymphoma--a case report. Indian J Dermatol Venereol Leprol. 2004 May-Jun; 70(3):168-71. PMID: 17642599.
    Citations: 1     Fields:    
  114. Meyers SW, Bercovitch L, Polley K, Taira J, DeCamp N, Mahalingam M, Grillone G, Grande D. Massive exophytic abscesses and fibrotic masses of the chin: a variant of the follicular occlusion triad. J Am Acad Dermatol. 2003 May; 48(5 Suppl):S47-50. PMID: 12734472.
    Citations:    Fields:    Translation:Humans
  115. Mahalingam M, Palko M, Steinberg-Benjes L, Goldberg LJ. Amyloidosis of the auricular concha: an uncommon variant of localized cutaneous amyloidosis. Am J Dermatopathol. 2002 Oct; 24(5):447-8. PMID: 12357209.
    Citations: 1     Fields:    Translation:Humans
  116. Mahalingam M, Kim E, Bhawan J. Morphea-like tattoo reaction. Am J Dermatopathol. 2002 Oct; 24(5):392-5. PMID: 12357198.
    Citations: 2     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Mahalingam's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (470)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.